Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Predict S.P.A. Class B ( (IT:PRE) ) just unveiled an update.
Predict S.p.A. has secured a €65,570 order for two Mistral Samplers from the Politecnico di Bari, aimed at advancing research in breath analysis. This sale supports the university’s research projects funded by the D3-4 Health foundation and enhances Predict’s Mistral Strategic Business Unit, bolstering its position in the breath analysis field and fostering scientific innovation.
The most recent analyst rating on (IT:PRE) stock is a Buy with a EUR1.45 price target. To see the full list of analyst forecasts on Predict S.P.A. Class B stock, see the IT:PRE Stock Forecast page.
More about Predict S.P.A. Class B
Predict S.p.A., founded in 2008 in Bari, is an innovative SME in the healthcare sector, organized into four Strategic Business Units. These units focus on in vivo diagnostic imaging, breath analysis, and digital healthcare technologies, including augmented reality and robotics. The company is known for its innovative solutions like Mistral for non-invasive oncological screenings and Aphel, an AI platform supporting healthcare staff.
Average Trading Volume: 16,990
Technical Sentiment Signal: Sell
Current Market Cap: €5.27M
For detailed information about PRE stock, go to TipRanks’ Stock Analysis page.